文献速递心境障碍

半结构化与全结构化诊断访谈对重性抑郁分类概率的影响

Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews.
PubMed 文献 · Br J Psychiatry · 2018-05-02

该研究基于57项原始研究、17 158名参与者的个体数据,分析访谈方法与重性抑郁分类几率的关系。结果显示,MINI较CIDI更易将受试者分类为重性抑郁;全结构化访谈与半结构化访谈在低、中症状水平下分类几率无显著差异,但在高症状水平下全结构化访谈分类几率显著更低。

要点

  • MINI分类为重性抑郁的几率显著高于CIDI(OR=2.10)。
  • 高抑郁症状(PHQ-9≥16)时全结构化访谈分类几率显著低于半结构化访谈。
  • 低、中症状水平下两种访谈方法分类几率无显著差异。

核心结论

  • MINI可能比CIDI识别出更多抑郁个体,半结构化与全结构化访谈可能不可互换,但结果需重复验证。

研究设计与样本

  • 基于PHQ-9诊断准确性个体参与者数据Meta分析的数据,拟合二项广义线性混合模型。
  • 共纳入57项原始研究、17 158名参与者,其中2287例为重性抑郁。

主要发现

  • 全结构化访谈中,MINI分类为重性抑郁的几率高于CIDI(OR=2.10;95%CI=1.15-3.87)。
  • 与半结构化访谈相比,全结构化访谈(排除MINI)在低症状水平(PHQ-9≤6)分类几率无显著差异(OR=3.13;95%CI=0.98-10.00)。
  • 中症状水平(PHQ-9 7-15)分类几率无显著差异(OR=0.96;95%CI=0.56-1.66)。
  • 高症状水平(PHQ-9≥16)全结构化访谈分类几率显著更低(OR=0.50;95%CI=0.26-0.97)。

临床怎么用

  • 临床研究中选用诊断访谈工具时需注意MINI与CIDI分类几率存在差异。
  • 半结构化与全结构化访谈在高症状水平下分类几率不同,不可随意互换。

局限性

  • 作者指出结果需重复验证。
  • 部分作者报告了与多家药企的利益关系,均声明在提交工作之外。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Different diagnostic interviews are used as reference standards for major depression classification in research. Semi-structured interviews involve clinical judgement, whereas fully structured interviews are completely scripted. The Mini International Neuropsychiatric Interview (MINI), a brief fully structured interview, is also sometimes used. It is not known whether interview method is associated with probability of major depression classification.AimsTo evaluate the association between interview method and odds of major depression classification, controlling for depressive symptom scores and participant characteristics. METHOD: Data collected for an individual participant data meta-analysis of Patient Health Questionnaire-9 (PHQ-9) diagnostic accuracy were analysed and binomial generalised linear mixed models were fit. RESULTS: A total of 17 158 participants (2287 with major depression) from 57 primary studies were analysed. Among fully structured interviews, odds of major depression were higher for the MINI compared with the Composite International Diagnostic Interview (CIDI) (odds ratio (OR) = 2.10; 95% CI = 1.15-3.87). Compared with semi-structured interviews, fully structured interviews (MINI excluded) were non-significantly more likely to classify participants with low-level depressive symptoms (PHQ-9 scores ≤6) as having major depression (OR = 3.13; 95% CI = 0.98-10.00), similarly likely for moderate-level symptoms (PHQ-9 scores 7-15) (OR = 0.96; 95% CI = 0.56-1.66) and significantly less likely for high-level symptoms (PHQ-9 scores ≥16) (OR = 0.50; 95% CI = 0.26-0.97). CONCLUSIONS: The MINI may identify more people as depressed than the CIDI, and semi-structured and fully structured interviews may not be interchangeable methods, but these results should be replicated.Declaration of interestDrs Jetté and Patten declare that they received a grant, outside the submitted work, from the Hotchkiss Brain Institute, which was jointly funded by the Institute and Pfizer. Pfizer was the original sponsor of the development of the PHQ-9, which is now in the public domain. Dr Chan is a steering committee member or consultant of Astra Zeneca, Bayer, Lilly, MSD and Pfizer. She has received sponsorships and honorarium for giving lectures and providing consultancy and her affiliated institution has received research grants from these companies. Dr Hegerl declares that within the past 3 years, he was an advisory board member for Lundbeck, Servier and Otsuka Pharma; a consultant for Bayer Pharma; and a speaker for Medice Arzneimittel, Novartis, and Roche Pharma, all outside the submitted work. Dr Inagaki declares that he has received grants from Novartis Pharma, lecture fees from Pfizer, Mochida, Shionogi, Sumitomo Dainippon Pharma, Daiichi-Sankyo, Meiji Seika and Takeda, and royalties from Nippon Hyoron Sha, Nanzando, Seiwa Shoten, Igaku-shoin and Technomics, all outside of the submitted work. Dr Yamada reports personal fees from Meiji Seika Pharma Co., Ltd., MSD K.K., Asahi Kasei Pharma Corporation, Seishin Shobo, Seiwa Shoten Co., Ltd., Igaku-shoin Ltd., Chugai Igakusha and Sentan Igakusha, all outside the submitted work. All other authors declare no competing interests. No funder had any role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Levis B, Benedetti A, Riehm KE, et al. Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews. Br J Psychiatry. 2018. PMID: 29717691. doi:10.1192/bjp.2018.54

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。